ArticleFrontiers in oncology2022

Case report: Posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer.

Yuki Matsuura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.